Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan Patent Number: ZL 2007 1 004 1525.X Issue Date: Oct. 27, 2010

A Synthetic method of Docetaxel Patent Number: ZL 2006 1 0116735.6 Issue Date: 30 July, 2008

A method of Extracting and Purifying 10- Deacetyl Baccatin III Patent Number: ZL 03 1 29635.1 Issue Date: 18 May, 2005

Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.